No profile data available.
Sonoma Pharmaceuticals, Inc. (SNOA) is a healthcare company in the healthcare consumable products industry, based in Boulder, United States, with about 10 full-time employees.
It reported revenue of $14.29 million for fiscal year 2025, up 12.2% from fiscal year 2024, and net income of -$3.46 million. In Q3 2026 (the quarter ended December 31, 2025) revenue was $4.35 million, up 22.0% from a year before. Its largest business segment, Human Care, brought in 91% of segment revenue in fiscal year 2026. Its market capitalization was $5.89 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Sonoma Pharmaceuticals reported $14.29 million in revenue for fiscal year 2025, up 12.2% from $12.74 million in fiscal year 2024. In Q3 2026 revenue was $4.35 million.
Human Care, with $17.68 million or 91% of segment revenue in fiscal year 2026. Next: Animal Care (9%).
$5.89 million as of October 9, 2026.
Listed companies of a similar size in the same industry (healthcare consumable products) include Sanuwave Health, Inc. (SNWV), Cuprina Holdings (Cayman) Limited (CUPR), United Health Products, Inc. (UEEC), Procyon Corporation (PCYN).